High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine - McNamara, L A; Topaz, N; Wang, X; Hariri, S; Fox, L; MacNeil, J R (MMWR Morb Mortal Wkly Rep, 2017)